Side-by-side distribution
Formulation Scientist
$99,840
median · per year, annualized USD
- Disclosing
- 50%
- Live roles
- 8
Pharmacy Technician
$49,400
median · per year, annualized USD
- Disclosing
- 56.1%
- Live roles
- 155
Highest-paying jobs
Manager/Principal Scientist Research & Development - Polymer Formulation Devices
Senior Associate Scientist (Contract), Formulation Development
Confections Formulation Scientist
Associate Scientist I (Contract), Formulation Development
Highest-paying jobs
Pharmacy Technician Trainee - Boynton Beach, FL (Temp)
Band 7 Pharmacy Technician (Medicines Procurement) - Kent
Certified Pharmacy Technician (CPhT) Learning Mentor
Certified Pharmacy Technician (CPhT) - Live Instructor
Locum Band 6 Pharmacy Technician - Lincolnshire
Locum Pharmacy Technician - Chelsea, London
Band 6 Clinical Trials Pharmacy Technician - South London
Specialty Pharmacy Technician
Specialty Pharmacy Technician - Russian Speaking
Specialty Pharmacy Technician
Top companies hiring
| Company | Median | Roles |
|---|---|---|
|
Vaxcyte
|
$99,840 | 2 |
|
Cresilon, Inc.
|
$155,000 | 1 |
|
Curaleaf
|
$82,500 | 1 |
Top companies hiring
| Company | Median | Roles |
|---|---|---|
| SH Shields Health Solutions | $55,000 | 21 |
| PH Pulse Healthcare | $56,946 | 16 |
PHIL
|
$45,760 | 8 |
|
Ro
|
$60,750 | 7 |
Good Pill
|
$41,600 | 6 |
Hims & Hers
|
$47,840 | 4 |
Montu UK
|
$58,271 | 3 |
Mixlab
|
$53,040 | 3 |
Formulation Scientist vs Pharmacy Technician: which pays more?
The median for Formulation Scientist is $99,840 per year (typically $83,025–$126,110), versus $49,400 for Pharmacy Technician ($45,760–$57,912). That puts Formulation Scientist about 102% ahead at the median.
Both figures are computed live from active listings on JobsRadar and normalized to annualized USD, so Formulation Scientist and Pharmacy Technician are compared on equal terms regardless of the currency each role was originally posted in. Only roles that publish a salary range feed the medians; numbers refresh every few hours as new roles post and older ones close, so this comparison reflects the market right now rather than a fixed survey. Use it as a directional benchmark when weighing one path against the other.